tirzepatide weight loss efficacy vs semaglutide differences safety or Tirzepatide: Which is Better for You? Tirzepatide vs Oral Semaglutide: What – Retatrutide for weight loss: Study

A prespecified analysis of pooled data from the STEP-HFpEF and STEP-HFpEF DM trials demonstrated that significantly more patients treated with Wegovy 2.4 mg SC once weekly had an improvement of at least one New York Heart Association (NYHA) functional class compared to those who received placebo (32.6% versus 21.5%, respectively

Expanded access to AOM treatments avoids or delays obesity-related comorbidities, improving the quality and quantity of life for a set of people

Side effects are minimal and typically limited to slight soreness at the injection site

No scheduled followups, lab checks, or afterhours support

The dosage is increased every week to a maximum dose of 3.0 mg